Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP [electronic resource]
Producer: 20180118Description: 895-902 p. digitalISSN:- 1592-8721
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Remission Induction
- Rituximab -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.